Logo image of DIM.PA

SARTORIUS STEDIM BIOTECH (DIM.PA) Stock Fundamental Analysis

EPA:DIM - Euronext Paris - Matif - FR0013154002 - Common Stock - Currency: EUR

187.1  -6.9 (-3.56%)

Fundamental Rating

4

DIM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 18 industry peers in the Life Sciences Tools & Services industry. DIM has only an average score on both its financial health and profitability. While showing a medium growth rate, DIM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year DIM was profitable.
In the past year DIM had a positive cash flow from operations.
In the past 5 years DIM has always been profitable.
Each year in the past 5 years DIM had a positive operating cash flow.
DIM.PA Yearly Net Income VS EBIT VS OCF VS FCFDIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

The Return On Assets of DIM (2.46%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 5.14%, DIM is in line with its industry, outperforming 44.44% of the companies in the same industry.
DIM has a worse Return On Invested Capital (4.36%) than 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DIM is above the industry average of 6.90%.
The last Return On Invested Capital (4.36%) for DIM is well below the 3 year average (10.41%), which needs to be investigated, but indicates that DIM had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.46%
ROE 5.14%
ROIC 4.36%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
DIM.PA Yearly ROA, ROE, ROICDIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

DIM has a better Profit Margin (7.15%) than 61.11% of its industry peers.
In the last couple of years the Profit Margin of DIM has declined.
DIM has a Operating Margin (14.05%) which is comparable to the rest of the industry.
DIM's Operating Margin has declined in the last couple of years.
The Gross Margin of DIM (43.89%) is better than 66.67% of its industry peers.
DIM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.05%
PM (TTM) 7.15%
GM 43.89%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
DIM.PA Yearly Profit, Operating, Gross MarginsDIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DIM is still creating some value.
DIM has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DIM has been increased compared to 5 years ago.
Compared to 1 year ago, DIM has an improved debt to assets ratio.
DIM.PA Yearly Shares OutstandingDIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DIM.PA Yearly Total Debt VS Total AssetsDIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 3.90 indicates that DIM is not in any danger for bankruptcy at the moment.
DIM has a better Altman-Z score (3.90) than 83.33% of its industry peers.
The Debt to FCF ratio of DIM is 5.03, which is a neutral value as it means it would take DIM, 5.03 years of fcf income to pay off all of its debts.
DIM has a Debt to FCF ratio (5.03) which is comparable to the rest of the industry.
DIM has a Debt/Equity ratio of 0.72. This is a neutral value indicating DIM is somewhat dependend on debt financing.
The Debt to Equity ratio of DIM (0.72) is worse than 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 5.03
Altman-Z 3.9
ROIC/WACC0.52
WACC8.43%
DIM.PA Yearly LT Debt VS Equity VS FCFDIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.85 indicates that DIM should not have too much problems paying its short term obligations.
DIM has a Current ratio of 1.85. This is in the better half of the industry: DIM outperforms 72.22% of its industry peers.
A Quick Ratio of 1.14 indicates that DIM should not have too much problems paying its short term obligations.
DIM has a Quick ratio of 1.14. This is comparable to the rest of the industry: DIM outperforms 55.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.14
DIM.PA Yearly Current Assets VS Current LiabilitesDIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

5

3. Growth

3.1 Past

DIM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.97%.
The Earnings Per Share has been growing slightly by 4.19% on average over the past years.
Looking at the last year, DIM shows a small growth in Revenue. The Revenue has grown by 5.21% in the last year.
The Revenue has been growing by 14.05% on average over the past years. This is quite good.
EPS 1Y (TTM)4.97%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%34.88%
Revenue 1Y (TTM)5.21%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%11.65%

3.2 Future

Based on estimates for the next years, DIM will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.34% on average per year.
DIM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.61% yearly.
EPS Next Y23.98%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
EPS Next 5Y19.34%
Revenue Next Year8.49%
Revenue Next 2Y9.67%
Revenue Next 3Y10.37%
Revenue Next 5Y9.61%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DIM.PA Yearly Revenue VS EstimatesDIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
DIM.PA Yearly EPS VS EstimatesDIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 49.24, DIM can be considered very expensive at the moment.
83.33% of the companies in the same industry are cheaper than DIM, based on the Price/Earnings ratio.
DIM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.25.
A Price/Forward Earnings ratio of 33.93 indicates a quite expensive valuation of DIM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DIM indicates a rather expensive valuation: DIM more expensive than 83.33% of the companies listed in the same industry.
DIM's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.15.
Industry RankSector Rank
PE 49.24
Fwd PE 33.93
DIM.PA Price Earnings VS Forward Price EarningsDIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DIM is valued expensively inside the industry as 83.33% of the companies are valued cheaper.
66.67% of the companies in the same industry are cheaper than DIM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 31.2
EV/EBITDA 29.67
DIM.PA Per share dataDIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DIM does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as DIM's earnings are expected to grow with 24.81% in the coming years.
PEG (NY)2.05
PEG (5Y)11.74
EPS Next 2Y25.51%
EPS Next 3Y24.81%

More info and screens

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.36%, DIM is not a good candidate for dividend investing.
DIM's Dividend Yield is slightly below the industry average, which is at 0.87.
With a Dividend Yield of 0.36, DIM pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 0.36%

5.2 History

The dividend of DIM has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
DIM.PA Yearly Dividends per shareDIM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

DIM pays out 32.84% of its income as dividend. This is a sustainable payout ratio.
The dividend of DIM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP32.84%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
DIM.PA Yearly Income VS Free CF VS DividendDIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
DIM.PA Dividend Payout.DIM.PA Dividend Payout, showing the Payout Ratio.DIM.PA Dividend Payout.PayoutRetained Earnings

More info and screens

SARTORIUS STEDIM BIOTECH

EPA:DIM (6/2/2025, 9:42:23 AM)

187.1

-6.9 (-3.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)04-16 2025-04-16/bmo
Earnings (Next)07-22 2025-07-22
Inst Owners11.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.21B
Analysts78.89
Price Target248.41 (32.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.36%
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP32.84%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.91%
Min EPS beat(2)7.63%
Max EPS beat(2)22.18%
EPS beat(4)2
Avg EPS beat(4)0.98%
Min EPS beat(4)-20.27%
Max EPS beat(4)22.18%
EPS beat(8)2
Avg EPS beat(8)-16.9%
EPS beat(12)2
Avg EPS beat(12)-16.88%
EPS beat(16)5
Avg EPS beat(16)-11.85%
Revenue beat(2)2
Avg Revenue beat(2)3.21%
Min Revenue beat(2)2.91%
Max Revenue beat(2)3.52%
Revenue beat(4)3
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)3.52%
Revenue beat(8)4
Avg Revenue beat(8)-1.35%
Revenue beat(12)4
Avg Revenue beat(12)-1.7%
Revenue beat(16)8
Avg Revenue beat(16)12.23%
PT rev (1m)-1.71%
PT rev (3m)-0.06%
EPS NQ rev (1m)1.98%
EPS NQ rev (3m)-0.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.03%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-4.53%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-0.88%
Valuation
Industry RankSector Rank
PE 49.24
Fwd PE 33.93
P/S 6.37
P/FCF 31.2
P/OCF 20.71
P/B 4.58
P/tB N/A
EV/EBITDA 29.67
EPS(TTM)3.8
EY2.03%
EPS(NY)5.51
Fwd EY2.95%
FCF(TTM)6
FCFY3.2%
OCF(TTM)9.04
OCFY4.83%
SpS29.36
BVpS40.81
TBVpS-5.43
PEG (NY)2.05
PEG (5Y)11.74
Profitability
Industry RankSector Rank
ROA 2.46%
ROE 5.14%
ROCE 5.47%
ROIC 4.36%
ROICexc 4.84%
ROICexgc 15.14%
OM 14.05%
PM (TTM) 7.15%
GM 43.89%
FCFM 20.42%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexcg growth 3Y-36.77%
ROICexcg growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score7
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 5.03
Debt/EBITDA 4
Cap/Depr 95.85%
Cap/Sales 10.35%
Interest Coverage 2.25
Cash Conversion 123.84%
Profit Quality 285.66%
Current Ratio 1.85
Quick Ratio 1.14
Altman-Z 3.9
F-Score7
WACC8.43%
ROIC/WACC0.52
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)4.97%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%34.88%
EPS Next Y23.98%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
EPS Next 5Y19.34%
Revenue 1Y (TTM)5.21%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%11.65%
Revenue Next Year8.49%
Revenue Next 2Y9.67%
Revenue Next 3Y10.37%
Revenue Next 5Y9.61%
EBIT growth 1Y-0.84%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year91.76%
EBIT Next 3Y37.04%
EBIT Next 5Y24.38%
FCF growth 1Y325.99%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y45.08%
OCF growth 3Y5.11%
OCF growth 5Y21.32%